Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Focal atrichia helps diagnose female pattern hair loss.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Rituximab can cause skin issues, but baricitinib may help improve them.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Better models and evaluation methods for alopecia areata are needed.

Adalimumab can cause complete hair loss in rare cases.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

A new gene variant in the DSP gene is linked to a unique type of hair loss.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

61 functional keratin genes were identified in dogs and horses, leading to updated gene annotations.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Skin aging reflects overall body aging and can indicate internal health conditions.